Analysts’ Viewpoint
The global mobile cardiac telemetry device market is expected to witness significant growth in the next few years due to increase in prevalence of cardiovascular diseases, technological advancements, and surge in demand for mobile cardiac telemetry monitors. Rise in the geriatric population and increase in disposable income are driving global mobile cardiac telemetry device market growth. Furthermore, surge in awareness about preventive healthcare and rise in adoption of mHealth solutions are fueling market expansion.
However, high cost associated with these devices, data security concerns, and lack of skilled professionals in developing countries are likely to hamper market development. Untapped markets such as Africa and South Asia offer lucrative opportunities for players in the industry. Leading manufacturers are focusing on partnering with telecom operators and healthcare providers to create novel and low cost devices to increase market share.
Mobile cardiac telemetry (MCT) is a medical device used to monitor the heart rate and rhythm of patients. It is a non-invasive device that is worn on the patient's chest and transmits data to a monitoring station. The device is used to detect and diagnose cardiac arrhythmias, or abnormal heart rhythms, and to monitor the patient's heart rate and rhythm over time. MCT devices are typically composed of a transmitter, a receiver, and a monitor. The transmitter is worn on the patient's chest and is connected to electrodes that measure the electrical activity of the heart. The transmitter then sends the data to the receiver, which is connected to a monitor. The monitor displays the data in real time, allowing the physician to monitor the patient's heart rate and rhythm.
MCT devices offer several advantages over traditional cardiac monitoring methods. These are non-invasive i.e., these do not require surgery or other invasive procedures. These devices are also portable, allowing the patient to move around while being monitored. Additionally, MCT devices are able to detect and diagnose arrhythmias more quickly and accurately than traditional methods. However, MCT devices are expensive and require frequent maintenance and calibration.
Improvements in mobile cardiac telemetry devices have enabled the development of more sophisticated and accurate devices that can monitor a patient's heart rate and rhythm. For example, in April 2020, Abbott Laboratories launched the Confirm Rx Insertable Cardiac Monitor, a device that can detect and monitor cardiac arrhythmias. This device is the first of its kind to be approved by the U.S. Food and Drug Administration (FDA) and is expected to revolutionize the way cardiac arrhythmias are monitored and treated.
Developments in mobile cardiac telemetry device market, such as cloud-based platforms and mobile applications, have enabled remote monitoring of patients, allowing healthcare providers to monitor patients' heart rate and rhythm from anywhere. This has enabled healthcare providers to offer better care to patients and has also increased demand for mobile cardiac telemetry devices.
Increase in prevalence of cardiovascular diseases is another key driver of the global mobile cardiac telemetry device market. According to the World Health Organization, cardiovascular diseases are the leading cause of death globally, accounting for 17.9 million deaths in 2016. This has led to increase in demand for cardiac monitoring devices, as these can help healthcare providers detect and monitor cardiac arrhythmias and other cardiac conditions. Furthermore, rise in prevalence of cardiovascular diseases has led to increase in demand for remote monitoring devices, as these can help healthcare providers monitor their patients' heart rate and rhythm from anywhere.
In terms of application, the lead-based segment accounted for the largest share of the global mobile cardiac telemetry device market in 2022. This is ascribed to their ability to provide accurate and reliable data for the diagnosis and monitoring of cardiac arrhythmias. The lead-based segment has been split into single leads, dual leads, three leads, four leads, five leads, and six or more leads.
The surge in demand for advanced technology in healthcare has led to an increase in the adoption of mobile cardiac telemetry devices with multiple leads. For instance, in March 2019, Abbott Laboratories launched a new mobile cardiac telemetry device called Confirm Rx Insertable Cardiac Monitor (ICM), which features a five-lead system that provides physicians with more comprehensive data about their patients’ heart rhythms than traditional two or three lead systems. This device helps physicians detect arrhythmias earlier and more accurately than ever before. Thus, technological advancements are expected to drive the lead-based segment during the forecast period.
In terms of disease indication, the heart failure segment dominated the global market in 2022. This is ascribed to the rise in the prevalence of cardiovascular diseases across all age groups globally. According to the World Health Organization (WHO), 17 million people succumbed to cardiovascular diseases in 2016, which accounted for 31% of all global deaths that year. Moreover, WHO reported that around 85 million people worldwide were suffering from heart failure as of 2019, which is expected to increase significantly over time due to lifestyle changes such as unhealthy diets and lack of physical activity. This has resulted in increase in demand for advanced medical devices, such as mobile cardiac telemetry devices for diagnosis and monitoring purposes, which is likely to augment the segment during the forecast period.
Based on end-user, the hospitals segment held the largest share of the global mobile cardiac telemetry device market in 2022. Surge in prevalence of cardiovascular diseases is one of the major factors driving the segment. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally. This has led to increase in demand for cardiac monitoring devices, which, in turn, is propelling the hospitals segment. Surge in number of government initiatives to promote the adoption of cardiac monitoring devices is fueling the hospitals segment. For instance, in April 2020, the Government of India launched the Pradhan Mantri Jan Arogya Yojana (PMJAY) to provide free healthcare services to the poor. This scheme includes the provision of cardiac monitoring devices, which is expected to propel the hospitals segment.
Increase in number of strategic collaborations between hospitals and device manufacturers is bolstering the hospitals segment. For instance, in April 2021, Philips and the University of Michigan Health System announced a strategic collaboration to develop and deploy advanced cardiac monitoring solutions.
North America dominated the global market in 2022. The region is projected to account for the largest share of the market due to rise in prevalence of cardiac diseases and well-developed healthcare infrastructure. Moreover, increase in adoption of mobile cardiac telemetry devices, such as Holter monitors, event recorders, and telemetry systems, is driving the market in North America. In April 2021, Abbott Laboratories launched a Holter monitor, the Confirm Rx ICM, which is an insertable cardiac monitor that can detect cardiac arrhythmias.
Asia Pacific is the fastest-growing region in the mobile cardiac telemetry device market. The increase in prevalence of cardiac diseases, rise in awareness about cardiac health, and surge in investments by global players in this region are driving the growth of the market.
The mobile cardiac telemetry device industry report includes vital information about the mobile cardiac telemetry device market's top players. Companies focus on strategies such as product launches, divestitures, mergers & acquisitions (M&A), and partnerships to strengthen their position in the market. BioTelemetry, Inc., ScottCare, Biotricity, Inc., Welch Allyn, Applied Cardiac Systems, Inc., Medicomp, Inc., Preventice Solutions, Telerhythmics LLC, Zoll Medical Corporation and iRhythm Technologies, Inc. are prominent players in the global market.
Each of these players in the market has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 942.7 Mn |
|
Market Forecast Value in 2031 |
More than US$ 2.5 Bn |
|
Compound Annual Growth Rate (CAGR) |
11.6% |
|
Forecast Period |
2023–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Mn/Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global industry was valued at US$ 942.7 Mn in 2022.
It is projected to reach more than US$ 2.5 Bn by 2031.
The CAGR is anticipated to be 11.6% from 2023 to 2031.
Technological advancements and increase in prevalence of cardiovascular diseases are driving the market.
The lead-based segment held the largest share in 2022.
North America is expected to account for significant market share during the forecast period.
BioTelemetry, Inc., ScottCare, Biotricity, Inc., Welch Allyn, Applied Cardiac Systems, Inc., Medicomp, Inc., Preventice Solutions, Telerhythmics LLC, Zoll Medical Corporation, and iRhythm Technologies, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Mobile Cardiac Telemetry Device Market
4. Market Overview
4.1. Introduction
4.1.1. Disease Indication Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Technological Advancement
5.2. Regulatory Analysis
5.3. Disease Incidence and Prevalence
5.4. COVID-19 Impact Analysis
6. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Application, 2017 – 2031
6.3.1. Lead-based
6.3.2. Patch-based
6.4. Market Attractiveness Analysis, by Application
7. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by Disease Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Disease Indication, 2017–2031
7.3.1. Angina Pectoris
7.3.2. Atherosclerosis
7.3.3. Heart Failure
7.3.4. Others
7.4. Market Attractiveness, by Disease Indication
8. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Diagnostic Centers
8.3.4. Home Care Settings
8.3.5. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Mobile Cardiac Telemetry Device Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Application, 2017–2031
10.2.1. Lead-based
10.2.2. Patch-based
10.3. Market Value Forecast, by Disease Indication, 2017–2031
10.3.1. Angina Pectoris
10.3.2. Atherosclerosis
10.3.3. Heart Failure
10.3.4. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Specialty Clinics
10.4.3. Diagnostic Centers
10.4.4. Home Care Settings
10.4.5. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Application
10.6.2. By Disease Indication
10.6.3. By End-user
10.6.4. By Country
11. Europe Mobile Cardiac Telemetry Device Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Application, 2017–2031
11.2.1. Lead-based
11.2.2. Patch-based
11.3. Market Value Forecast, by Disease Indication, 2017–2031
11.3.1. Angina Pectoris
11.3.2. Atherosclerosis
11.3.3. Heart Failure
11.3.4. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Specialty Clinics
11.4.3. Diagnostic Centers
11.4.4. Home Care Settings
11.4.5. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Application
11.6.2. By Disease Indication
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Mobile Cardiac Telemetry Device Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Application, 2017–2031
12.2.1. Lead-based
12.2.2. Patch-based
12.3. Market Value Forecast, by Disease Indication, 2017–2031
12.3.1. Angina Pectoris
12.3.2. Atherosclerosis
12.3.3. Heart Failure
12.3.4. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Specialty Clinics
12.4.3. Diagnostic Centers
12.4.4. Home Care Settings
12.4.5. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Application
12.6.2. By Disease Indication
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Mobile Cardiac Telemetry Device Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Application, 2017–2031
13.2.1. Lead-based
13.2.2. Patch-based
13.3. Market Value Forecast, by Disease Indication, 2017–2031
13.3.1. Angina Pectoris
13.3.2. Atherosclerosis
13.3.3. Heart Failure
13.3.4. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Specialty Clinics
13.4.3. Diagnostic Centers
13.4.4. Home Care Settings
13.4.5. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Application
13.6.2. By Disease Indication
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Mobile Cardiac Telemetry Device Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Application, 2017–2031
14.2.1. Lead-based
14.2.2. Patch-based
14.3. Market Value Forecast, by Disease Indication, 2017–2031
14.3.1. Angina Pectoris
14.3.2. Atherosclerosis
14.3.3. Heart Failure
14.3.4. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Specialty Clinics
14.4.3. Diagnostic Centers
14.4.4. Home Care Settings
14.4.5. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. Brazil
14.5.2. Mexico
14.5.3. Rest of Latin America
14.6. Market Attractiveness Analysis
14.6.1. By Application
14.6.2. By Disease Indication
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2022
15.3. Company Profiles
15.3.1. BioTelemetry, Inc.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Test Application Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. ScottCare
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Test Application Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Biotricity Inc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Test Application Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Welch Allyn
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Test Application Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Applied Cardiac Systems, Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Test Application Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Medicomp, Inc.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Test Application Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Preventice Solutions
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Test Application Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Telerhythmics LLC
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Test Application Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Zoll Medical Corporation
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Test Application Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. iRhythm Technologies, Inc.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Test Application Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
List of Tables
Table 1: Global overview of Surgical Mobile Cardiac Telemetry Device
Table 2: Regional overview of Surgical Mobile Cardiac Telemetry Device
Table 4: North America Overview of Surgical Mobile Cardiac Telemetry Device
Table 4: Asia Pacific overview of Surgical Mobile Cardiac Telemetry Device
Table 5: Global Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023–2031
Table 6: Global Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023–2031
Table 7: Global Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 8: Global Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Region, 2023–2031
Table 9: North America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Country, 2023–2031
Table 10: North America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023–2031
Table 11: North America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023–2031
Table 12: North America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 13: Europe Surgical Mobile Cardiac Telemetry Device Revenue (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 14: Europe Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023–2031
Table 15: Europe Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023–2031
Table 16: Europe Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 17: Asia Pacific Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 18: Asia Pacific Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023–2031
Table 19: Asia Pacific Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023–2031
Table 20: Asia Pacific Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 21: Latin America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 22: Latin America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023–2031
Table 23: Latin America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023–2031
Table 24: Latin America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 25: Middle East & Africa Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 26: Middle East & Africa Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023–2031
Table 27: Middle East & Africa Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023–2031
Table 28: Middle East & Africa Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023–2031
List of Figures
Figure 01: Global Mobile Cardiac Telemetry Device Market
Figure 02: Global Mobile Cardiac Telemetry Device Market Size (US$ Mn) Forecast, 2017–2031
Figure 03: Global Mobile Cardiac Telemetry Device Market Value Share, by Disease Indication (2022)
Figure 04: Global Mobile Cardiac Telemetry Device Market Value Share, by Application (2022)
Figure 05: Global Mobile Cardiac Telemetry Device Market Value Share, by End-user (2022)
Figure 06: Global Mobile Cardiac Telemetry Device Market Value Share, by Region (2022)
Figure 07: Global Mobile Cardiac Telemetry Device Market Value Share, by Application, 2022 and 2031
Figure 08: Global Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Application, 2023–2031
Figure 09: Global Mobile Cardiac Telemetry Device Market Value Share, by Disease Indication, 2022 and 2031
Figure 10: Global Mobile Cardiac Telemetry Device Market Attractiveness, by Disease Indication, 2023–2031
Figure 11: Global Mobile Cardiac Telemetry Device Market Value Share, by End-user, 2022 and 2031
Figure 12: Global Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by End-user, 2023–2031
Figure 13: Global Mobile Cardiac Telemetry Device Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
Figure 14: Global Mobile Cardiac Telemetry Device Market Value Share, by Region, 2023–2031
Figure 15: Global Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Region, 2023–2031
Figure 16: North America Mobile Cardiac Telemetry Device Market Value Share, by Application, 2022 and 2031
Figure 17: North America Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Application, 2023–2031
Figure 18: North America Mobile Cardiac Telemetry Device Market Value Share, by Disease Indication, 2022 and 2031
Figure 19: North America Mobile Cardiac Telemetry Device Market Attractiveness, by Disease Indication, 2023–2031
Figure 20: North America Mobile Cardiac Telemetry Device Market Value Share, by End-user, 2022 and 2031
Figure 21: North America Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by End-user, 2023–2031
Figure 22: North America Mobile Cardiac Telemetry Device Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
Figure 23: North America Mobile Cardiac Telemetry Device Market Value Share, by Country, 2023–2031
Figure 24: North America Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Country, 2023–2031
Figure 25: Europe Mobile Cardiac Telemetry Device Market Value Share, by Application, 2022 and 2031
Figure 26: Europe Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Application, 2023–2031
Figure 27: Europe Mobile Cardiac Telemetry Device Market Value Share, by Disease Indication, 2022 and 2031
Figure 28: Europe Mobile Cardiac Telemetry Device Market Attractiveness, by Disease Indication, 2023–2031
Figure 29: Europe Mobile Cardiac Telemetry Device Market Value Share, by End-user, 2022 and 2031
Figure 30: Europe Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by End-user, 2023–2031
Figure 31: Europe Mobile Cardiac Telemetry Device Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
Figure 32: Europe Mobile Cardiac Telemetry Device Market Value Share, by Country/Sub-region, 2022–2031
Figure 33: Europe Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 34: Asia Pacific Mobile Cardiac Telemetry Device Market Value Share, by Application, 2022 and 2031
Figure 35: Asia Pacific Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Application, 2023–2031
Figure 36: Asia Pacific Mobile Cardiac Telemetry Device Market Value Share, by Disease Indication, 2022 and 2031
Figure 37: Asia Pacific Mobile Cardiac Telemetry Device Market Attractiveness, by Disease Indication, 2023–2031
Figure 38: Asia Pacific Mobile Cardiac Telemetry Device Market Value Share, by End-user, 2022 and 2031
Figure 39: Asia Pacific Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by End-user, 2023–2031
Figure 40: Asia Pacific Mobile Cardiac Telemetry Device Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
Figure 41: Asia Pacific Mobile Cardiac Telemetry Device Market Value Share, by Country/Sub-region, 2022–2031
Figure 42: Asia Pacific Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 43: Latin America Mobile Cardiac Telemetry Device Market Value Share, by Application, 2022 and 2031
Figure 44: Latin America Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Application, 2023–2031
Figure 45: Latin America Mobile Cardiac Telemetry Device Market Value Share, by Disease Indication, 2022 and 2031
Figure 46: Latin America Mobile Cardiac Telemetry Device Market Attractiveness, by Disease Indication, 2023–2031
Figure 47: Latin America Mobile Cardiac Telemetry Device Market Value Share, by End-user, 2022 and 2031
Figure 48: Latin America Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by End-user, 2023–2031
Figure 49: Latin America Mobile Cardiac Telemetry Device Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
Figure 50: Latin America Mobile Cardiac Telemetry Device Market Value Share, by Country/Sub-region, 2022–2031
Figure 51: Latin America Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 52: Middle East & Africa Mobile Cardiac Telemetry Device Market Value Share, by Application, 2022 and 2031
Figure 53: Middle East & Africa Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Application, 2023–2031
Figure 54: Middle East & Africa Mobile Cardiac Telemetry Device Market Value Share, by Disease Indication, 2022 and 2031
Figure 55: Middle East & Africa Mobile Cardiac Telemetry Device Market Attractiveness, by Disease Indication, 2023–2031
Figure 56: Middle East & Africa Mobile Cardiac Telemetry Device Market Value Share, by End-user, 2022 and 2031
Figure 57: Middle East & Africa Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by End-user, 2023–2031
Figure 58: Middle East & Africa Mobile Cardiac Telemetry Device Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
Figure 59: Middle East & Africa Mobile Cardiac Telemetry Device Market Value Share, by Country/Sub-region, 2022–2031
Figure 60: Middle East & Africa Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 61: Global Mobile Cardiac Telemetry Device Market Share Analysis, by Company, 2022 (Estimated)
Figure 62: Global Mobile Cardiac Telemetry Device Market Performance, by Company, 2022
Figure 63: Competition Matrix
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Mobile Cardiac Telemetry Device Market
*86 figures and 60 tables includes